anti-CTLA-4	cytotoxic T-lymphocyte-associated antigen 4 inhibitor
anti-PD-1	programmed death-1 receptor inhibitor
anti-PD-L1	programmed death-1 receptor ligand inhibitor
APC	antigen-presenting cell
aTreg	activated Treg
CAF	cancer-associated fibroblast
CCL	CC chemokine ligand
CR	complete response
DAMP	danger-associated molecular pattern
DC	dendritic cell
ECT	electrochemotherapy
GET	gene electrotransfer
HMGB1	high mobility group box 1
ICD	immunogenic cell death
ICI	immune checkpoint inhibitor
IFN	interferon
IL	interleukin
M	macrophage
MDSC	myeloid-derived suppressor cell
MHC	major histocompatibility complex
NK cell	natural killer cell
NK cell transfer	NK cell transfer therapy
OS	overall survival
PD	progressive disease
PR	partial response
RCT	randomized controlled trial
STING	stimulator of interferon genes
TAA	tumor-associated antigen
TAM	tumor-associated macrophage
TGF	transforming growth-factor
TLR	toll-like receptor
TME	tumor microenvironment
TNF	tumor necrosis factor
Treg	regulatory T cell